Reviva to Participate in the A.G.P. Healthcare Company Showcase
Reviva Pharmaceuticals (NASDAQ: RVPH), a late-stage pharmaceutical company focused on developing therapies for central nervous system (CNS), inflammatory and cardiometabolic diseases, has announced its participation in the upcoming A.G.P. Healthcare Company Showcase. The company's Founder, President, and CEO, Laxminarayan Bhat, Ph.D., will engage in a fireside chat during the virtual event scheduled for May 21, 2025, at 2:00 p.m. EST.
Reviva Pharmaceuticals (NASDAQ: RVPH), un'azienda farmaceutica in fase avanzata specializzata nello sviluppo di terapie per il sistema nervoso centrale (SNC), malattie infiammatorie e cardiometaboliche, ha annunciato la sua partecipazione al prossimo A.G.P. Healthcare Company Showcase. Il fondatore, presidente e CEO dell'azienda, Laxminarayan Bhat, Ph.D., parteciperà a una conversazione informale durante l'evento virtuale previsto per il 21 maggio 2025 alle 14:00 EST.
Reviva Pharmaceuticals (NASDAQ: RVPH), una empresa farmacéutica en etapa avanzada enfocada en el desarrollo de terapias para el sistema nervioso central (SNC), enfermedades inflamatorias y cardiometabólicas, ha anunciado su participación en el próximo A.G.P. Healthcare Company Showcase. El fundador, presidente y CEO de la compañía, Laxminarayan Bhat, Ph.D., participará en una conversación informal durante el evento virtual programado para el 21 de mayo de 2025 a las 2:00 p.m. EST.
Reviva Pharmaceuticals (NASDAQ: RVPH)는 중추신경계(CNS), 염증성 및 심장대사 질환 치료제 개발에 주력하는 후기 단계 제약회사로, 다가오는 A.G.P. Healthcare Company Showcase에 참여한다고 발표했습니다. 회사의 창립자이자 사장 겸 CEO인 Laxminarayan Bhat, Ph.D.가 2025년 5월 21일 오후 2시 EST에 예정된 가상 행사에서 대담에 참여할 예정입니다.
Reviva Pharmaceuticals (NASDAQ : RVPH), une entreprise pharmaceutique en phase avancée spécialisée dans le développement de thérapies pour le système nerveux central (SNC), les maladies inflammatoires et cardiométaboliques, a annoncé sa participation au prochain A.G.P. Healthcare Company Showcase. Le fondateur, président et PDG de la société, Laxminarayan Bhat, Ph.D., participera à une discussion informelle lors de l'événement virtuel prévu le 21 mai 2025 à 14h00 EST.
Reviva Pharmaceuticals (NASDAQ: RVPH), ein Pharmaunternehmen in der Spätphase, das sich auf die Entwicklung von Therapien für das zentrale Nervensystem (ZNS), entzündliche und kardiometabolische Erkrankungen spezialisiert hat, hat seine Teilnahme an der kommenden A.G.P. Healthcare Company Showcase angekündigt. Der Gründer, Präsident und CEO des Unternehmens, Laxminarayan Bhat, Ph.D., wird an einem Fireside-Chat während der virtuellen Veranstaltung teilnehmen, die für den 21. Mai 2025 um 14:00 Uhr EST geplant ist.
- None.
- None.
CUPERTINO, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and cardiometabolic diseases, today announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will participate in a fireside chat at the A.G.P. Healthcare Company Showcase, taking place virtually May 21, 2025.
A.G.P. Healthcare Company Showcase
Format: Fireside Chat
Date: Wednesday, May 21, 2025
Time: 2:00 p.m. EST
Location: Virtual
Webcast Link: Click Here
About Reviva
Reviva is a late-stage biopharmaceutical company that discovers, develops, and seeks to commercialize next-generation therapeutics for diseases representing unmet medical needs and burdens to society, patients, and their families. Reviva's current pipeline focuses on the central nervous system (CNS), inflammatory and cardiometabolic diseases. Reviva's pipeline currently includes two drug candidates, brilaroxazine (RP5063) and RP1208. Both are new chemical entities discovered in-house. Reviva has been granted composition of matter patents for both brilaroxazine and RP1208 in the United States, Europe, and several other countries.
Corporate Contact:
Reviva Pharmaceuticals Holdings, Inc.
Laxminarayan Bhat, PhD
www.revivapharma.com
Investor Relations Contact:
LifeSci Advisors, LLC
Bruce Mackle
bmackle@lifesciadvisors.com
FAQ
When is Reviva Pharmaceuticals (RVPH) presenting at the A.G.P. Healthcare Company Showcase?
Who will represent RVPH at the A.G.P. Healthcare Company Showcase 2025?
What therapeutic areas does Reviva Pharmaceuticals (RVPH) focus on?
Is the A.G.P. Healthcare Company Showcase 2025 an in-person or virtual event?
